COMMENT

Negative AdCom vote for Amylyx’s ALS drug AMX0035, but hope remains

Will Russia’s invasion affect biopharmaceutical licensing agreements?

Fall from grace? What 2022 may have in stock for biopharmaceutical SPACs

R&D

Why did the cannabis industry blossom during the pandemic?

Global legal cannabis sales in 2020 were up by 45% on 2019, with several leading companies reporting triple-digit revenue growth

insight

How has AI helped in tackling Covid-19?

Many artificial intelligence tools have been developed in response to the Covid-19 pandemic, but their use has shown mixed results so far

insight

Europe reports the highest prevalence of chronic cough

comment

Could vaccine hesitancy impact hearing disorders?

Negative AdCom vote for Amylyx’s ALS drug AMX0035, but hope remains

Will Russia’s invasion affect biopharmaceutical licensing agreements?

Fall from grace? What 2022 may have in stock for biopharmaceutical SPACs

02/24/2024 12:08:14
  • Home | Tackling insulin prices
  • In this issue
  • CSafe Global
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Molnar-Institute Company Insight
  • Molnar-Institute
  • Comment
  • Why did the cannabis industry blossom during the pandemic?
  • Negative AdCom vote for Amylyx’s ALS drug AMX0035, but hope remains
  • Will Russia’s invasion affect biopharmaceutical licensing agreements?
  • Fall from grace? What 2022 may have in stock for biopharmaceutical SPACs
  • BEA Technologies
  • In Depth
  • Insulin pricing: could an e-commerce approach cut costs?
  • Bacteria and balance: how understanding the vaginal microbiome can help discover new drugs
  • Big pharma’s gradual retreat on clinical trials in Russia
  • Covid-19, flu combo vaccines an advance but with rollout quandaries
  • FDA shows unease about marketing approval applications based on single-country t
  • In Data
  • How big is the gender pay gap in the pharma industry in Britain?
  • Where is trade most likely to be disrupted in pharma from the Russian invasion o
  • Big data innovation among pharma companies dropped off in the last quarter
  • Event: Outsourcing in Clinical Trials Europe 2022
  • Events
  • Next issue
04/26/2022 00:00:00